These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20061960)

  • 1. Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies.
    Kinney AY; Gammon A; Coxworth J; Simonsen SE; Arce-Laretta M
    Genet Med; 2010 Feb; 12(2):105-15. PubMed ID: 20061960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA genetic counseling among at-risk Latinas in New York City: new beliefs shape new generation.
    Sussner KM; Edwards T; Villagra C; Rodriguez MC; Thompson HS; Jandorf L; Valdimarsdottir HB
    J Genet Couns; 2015 Feb; 24(1):134-48. PubMed ID: 25120034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City.
    Sussner KM; Jandorf L; Thompson HS; Valdimarsdottir HB
    Psychooncology; 2013 Jul; 22(7):1594-604. PubMed ID: 22987526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer.
    Gammon AD; Rothwell E; Simmons R; Lowery JT; Ballinger L; Hill DA; Boucher KM; Kinney AY
    J Genet Couns; 2011 Dec; 20(6):625-38. PubMed ID: 21691939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key messages for communicating information about BRCA1 and BRCA2 to women with breast or ovarian cancer: Consensus across health professionals and service users.
    Jacobs C; Pichert G; Harris J; Tucker K; Michie S
    Psychooncology; 2017 Nov; 26(11):1818-1824. PubMed ID: 28101941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interest and beliefs about BRCA genetic counseling among at-risk Latinas in New York City.
    Sussner KM; Jandorf L; Thompson HS; Valdimarsdottir HB
    J Genet Couns; 2010 Jun; 19(3):255-68. PubMed ID: 20151317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.
    Adams I; Christopher J; Williams KP; Sheppard VB
    J Cancer Educ; 2015 Jun; 30(2):344-52. PubMed ID: 25301325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.
    Høberg-Vetti H; Bjorvatn C; Fiane BE; Aas T; Woie K; Espelid H; Rusken T; Eikesdal HP; Listøl W; Haavind MT; Knappskog PM; Haukanes BI; Steen VM; Hoogerbrugge N
    Eur J Hum Genet; 2016 Jun; 24(6):881-8. PubMed ID: 26350514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into BRCA1/2 Genetic Counseling from Ethnically Diverse Latina Breast Cancer Survivors.
    Rajpal N; Muñoz J; Peshkin BN; Graves KD
    J Genet Couns; 2017 Dec; 26(6):1221-1237. PubMed ID: 28374142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and pilot testing of a training for bilingual community education professionals about hereditary breast and ovarian cancer among Latinas: ÁRBOLES Familiares.
    Vadaparampil ST; Moreno Botero L; Fuzzell L; Garcia J; Jandorf L; Hurtado-de-Mendoza A; Campos-Galvan C; Peshkin BN; Schwartz MD; Lopez K; Ricker C; Fiallos K; Quinn GP; Graves KD
    Transl Behav Med; 2022 Jan; 12(1):. PubMed ID: 34255089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
    Kelly K; Leventhal H; Marvin M; Toppmeyer D; Baran J; Schwalb M
    Cancer Control; 2004; 11(4):236-44. PubMed ID: 15284715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling.
    Tong A; Kelly S; Nusbaum R; Graves K; Peshkin BN; Valdimarsdottir HB; Wood M; McKinnon W; Garber J; McCormick SR; Jandorf L; Schwartz MD
    Psychooncology; 2015 Jan; 24(1):33-9. PubMed ID: 24839250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
    Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
    Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latinx attitudes, barriers, and experiences with genetic counseling and testing: A systematic review.
    Dron HA; Bucio D; Young JL; Tabor HK; Cho MK
    J Genet Couns; 2023 Feb; 32(1):166-181. PubMed ID: 36301246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).
    Peshkin BN; DeMarco TA; Garber JE; Valdimarsdottir HB; Patenaude AF; Schneider KA; Schwartz MD; Tercyak KP
    J Pediatr Psychol; 2009 Jul; 34(6):627-38. PubMed ID: 18385162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer.
    Gómez-Trillos S; Graves KD; Fiallos K; Schwartz MD; Peshkin BN; Hamilton H; Sheppard VB; Vadaparampil ST; Campos C; Cupertino AP; Alzamora MC; Lynce F; Hurtado-de-Mendoza A
    Transl Behav Med; 2023 May; 13(5):297-308. PubMed ID: 36694918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.
    Ratnayake P; Wakefield CE; Meiser B; Suthers G; Price MA; Duffy J; ; Tucker K
    Fam Cancer; 2011 Mar; 10(1):97-105. PubMed ID: 20878485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with preimplantation genetic diagnosis acceptance among women concerned about hereditary breast and ovarian cancer.
    Vadaparampil ST; Quinn GP; Knapp C; Malo TL; Friedman S
    Genet Med; 2009 Oct; 11(10):757-65. PubMed ID: 19710615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.